Remission and withdrawal of therapy in lupus nephritis

Gabriella Moroni, Francesca Raffiotta, Claudio Ponticelli

Research output: Contribution to journalReview article

Abstract

There is agreement that early diagnosis and aggressive treatment of lupus nephritis exacerbations are of paramount importance to achieve remission and prevent the development of irreversible lesions. There is less agreement about the optimal duration of maintenance treatment. Instead, the prolonged exposure to corticosteroids and/or immunosuppressive drugs can cause invalidating or even life-threatening complications. It is still unclear if these drugs can be safely withdrawn in lupus patients. We were able to completely withdraw therapy in around 1/3 of our patients after a follow-up of 5 years or more; 60 % of them never had to start therapy again. Based on our own experience, discontinuation of therapy should be applied only in selected cases, i.e. patients who received maintenance therapy for at least 5 years and are in complete renal remission for at least 3 years. Antimalarial agents are helpful in maintaining the remission after withdrawal of therapy. However, to achieve these goals, drugs should be tapered off very slowly and under strict surveillance. If all these prerequisites are satisfied, the withdrawal of therapy in patients with lupus nephritis may be considered safe, may improve the patients’ quality of life and may reduce the damage accrual.

Original languageEnglish
Pages (from-to)559-565
Number of pages7
JournalJournal of Nephrology
Volume29
Issue number4
DOIs
Publication statusPublished - Aug 1 2016

Fingerprint

Lupus Nephritis
Therapeutics
Pharmaceutical Preparations
Antimalarials
Immunosuppressive Agents
Early Diagnosis
Adrenal Cortex Hormones
Quality of Life
Kidney

Keywords

  • Corticosteroids
  • Immunosuppressive agents
  • Lupus nephritis
  • Remission
  • Withdrawal of therapy

ASJC Scopus subject areas

  • Nephrology

Cite this

Remission and withdrawal of therapy in lupus nephritis. / Moroni, Gabriella; Raffiotta, Francesca; Ponticelli, Claudio.

In: Journal of Nephrology, Vol. 29, No. 4, 01.08.2016, p. 559-565.

Research output: Contribution to journalReview article

Moroni, Gabriella ; Raffiotta, Francesca ; Ponticelli, Claudio. / Remission and withdrawal of therapy in lupus nephritis. In: Journal of Nephrology. 2016 ; Vol. 29, No. 4. pp. 559-565.
@article{10a7f964f3224138aa33b6e7fc81c920,
title = "Remission and withdrawal of therapy in lupus nephritis",
abstract = "There is agreement that early diagnosis and aggressive treatment of lupus nephritis exacerbations are of paramount importance to achieve remission and prevent the development of irreversible lesions. There is less agreement about the optimal duration of maintenance treatment. Instead, the prolonged exposure to corticosteroids and/or immunosuppressive drugs can cause invalidating or even life-threatening complications. It is still unclear if these drugs can be safely withdrawn in lupus patients. We were able to completely withdraw therapy in around 1/3 of our patients after a follow-up of 5 years or more; 60 {\%} of them never had to start therapy again. Based on our own experience, discontinuation of therapy should be applied only in selected cases, i.e. patients who received maintenance therapy for at least 5 years and are in complete renal remission for at least 3 years. Antimalarial agents are helpful in maintaining the remission after withdrawal of therapy. However, to achieve these goals, drugs should be tapered off very slowly and under strict surveillance. If all these prerequisites are satisfied, the withdrawal of therapy in patients with lupus nephritis may be considered safe, may improve the patients’ quality of life and may reduce the damage accrual.",
keywords = "Corticosteroids, Immunosuppressive agents, Lupus nephritis, Remission, Withdrawal of therapy",
author = "Gabriella Moroni and Francesca Raffiotta and Claudio Ponticelli",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s40620-016-0313-6",
language = "English",
volume = "29",
pages = "559--565",
journal = "Journal of Nephrology",
issn = "1121-8428",
publisher = "Springer International Publishing",
number = "4",

}

TY - JOUR

T1 - Remission and withdrawal of therapy in lupus nephritis

AU - Moroni, Gabriella

AU - Raffiotta, Francesca

AU - Ponticelli, Claudio

PY - 2016/8/1

Y1 - 2016/8/1

N2 - There is agreement that early diagnosis and aggressive treatment of lupus nephritis exacerbations are of paramount importance to achieve remission and prevent the development of irreversible lesions. There is less agreement about the optimal duration of maintenance treatment. Instead, the prolonged exposure to corticosteroids and/or immunosuppressive drugs can cause invalidating or even life-threatening complications. It is still unclear if these drugs can be safely withdrawn in lupus patients. We were able to completely withdraw therapy in around 1/3 of our patients after a follow-up of 5 years or more; 60 % of them never had to start therapy again. Based on our own experience, discontinuation of therapy should be applied only in selected cases, i.e. patients who received maintenance therapy for at least 5 years and are in complete renal remission for at least 3 years. Antimalarial agents are helpful in maintaining the remission after withdrawal of therapy. However, to achieve these goals, drugs should be tapered off very slowly and under strict surveillance. If all these prerequisites are satisfied, the withdrawal of therapy in patients with lupus nephritis may be considered safe, may improve the patients’ quality of life and may reduce the damage accrual.

AB - There is agreement that early diagnosis and aggressive treatment of lupus nephritis exacerbations are of paramount importance to achieve remission and prevent the development of irreversible lesions. There is less agreement about the optimal duration of maintenance treatment. Instead, the prolonged exposure to corticosteroids and/or immunosuppressive drugs can cause invalidating or even life-threatening complications. It is still unclear if these drugs can be safely withdrawn in lupus patients. We were able to completely withdraw therapy in around 1/3 of our patients after a follow-up of 5 years or more; 60 % of them never had to start therapy again. Based on our own experience, discontinuation of therapy should be applied only in selected cases, i.e. patients who received maintenance therapy for at least 5 years and are in complete renal remission for at least 3 years. Antimalarial agents are helpful in maintaining the remission after withdrawal of therapy. However, to achieve these goals, drugs should be tapered off very slowly and under strict surveillance. If all these prerequisites are satisfied, the withdrawal of therapy in patients with lupus nephritis may be considered safe, may improve the patients’ quality of life and may reduce the damage accrual.

KW - Corticosteroids

KW - Immunosuppressive agents

KW - Lupus nephritis

KW - Remission

KW - Withdrawal of therapy

UR - http://www.scopus.com/inward/record.url?scp=84978776356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978776356&partnerID=8YFLogxK

U2 - 10.1007/s40620-016-0313-6

DO - 10.1007/s40620-016-0313-6

M3 - Review article

VL - 29

SP - 559

EP - 565

JO - Journal of Nephrology

JF - Journal of Nephrology

SN - 1121-8428

IS - 4

ER -